Increased expression of P4HA2 has been detected in breast cancer (10), oral squamous cell carcinoma (11), papillary thyroid carcinoma (12), lung adenocarcinoma (13), B lymphoma (14), and glioma (15). Here, P4HA2 is linked to breast carcinoma.